{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T08:26:53Z","timestamp":1695025613175},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/jpn.0b013e318223ad14","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T03:55:16Z","timestamp":1372910116000},"page":"245-252","source":"Crossref","is-referenced-by-count":8,"title":["Preeclampsia"],"prefix":"10.1097","volume":"25","author":[{"given":"Nancy S.","family":"Townsend","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan B.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e3181a09fc0","article-title":"Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005.","volume":"113","author":"Berg","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajh.2008.20","article-title":"Secular trends in the rates of preeclampsia, eclampsia and gestational hypertension in the U.S.","volume":"21","author":"Wallis","year":"2008","journal-title":"Am J Hypertens"},{"issue":"2","key":"R3-9-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0884217504262970","article-title":"Hypertensive disorders of pregnancy.","volume":"33","author":"Peters","year":"2004","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"1","key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1552-6909.2006.00115.x","article-title":"Preeclampsia: exposing future cardiovascular risk in mothers and their children.","volume":"36","author":"Anderson","year":"2007","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.HYP.0000153461.58298.a4","article-title":"In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease.","volume":"45","author":"Myers","year":"2005","journal-title":"Hypertension"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0002-9378(91)90435-T","article-title":"High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone.","volume":"165","author":"Taylor","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"R8-9-20210126","first-page":"1061","article-title":"Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study.","volume":"76","author":"Easterling","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R9-9-20210126","first-page":"159","article-title":"ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia.","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"R11-9-20210126","first-page":"S1","article-title":"Am J Obstet Gynecol.","volume":"183","year":"2000","journal-title":""},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1471-0528.1994.tb13147.x","article-title":"Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.","volume":"101","author":"Halligan","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"R14-9-20210126","first-page":"978","article-title":"Maternal central hemodynamics in hypertensive disorders of pregnancy.","volume":"94","author":"Bosio","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"6","key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0002-9378(89)90869-7","article-title":"Preeclampsia: a hyperdynamic disease model.","volume":"160","author":"Easterling","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.316.7141.1343","article-title":"Fetal and maternal contributions to risk of preeclampsia: population based study.","volume":"316","author":"Lie","year":"1998","journal-title":"BMJ"},{"key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM200103223441201","article-title":"Paternal and maternal components of the predisposition to preeclampsia.","volume":"344","author":"Esplin","year":"2001","journal-title":"N Engl J Med"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bmj.38555.462685.8F","article-title":"Recurrence of preeclampsia across generations: exploring fetal and maternal genetic components in a population based cohort.","volume":"331","author":"Skjaerven","year":"2005","journal-title":"BMJ"},{"key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1552-6909.2008.00232.x","article-title":"Microarray technology applied to the complex disorder of preeclampsia.","volume":"37","author":"Founds","year":"2008","journal-title":"J Obstet Neonatal Nurs"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(06)68434-1","article-title":"Antioxidant supplementation in pre-eclampsia.","volume":"367","author":"Lindheimer","year":"2006","journal-title":"Lancet"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin therapy to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(00)03599-6","article-title":"Primary, secondary and tertiary prevention of pre-eclampsia.","volume":"357","author":"Dekker","year":"2001","journal-title":"Lancet"},{"key":"R23-9-20210126","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications.","volume":"354","author":"Rumbold","year":"2006","journal-title":"N Engl J Med"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/AOG.0b013e3181801d56","article-title":"Prediction and prevention of recurrent preeclampsia.","volume":"112","author":"Barton","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"R26-9-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199707103370201","article-title":"Trial of calcium to prevent preeclampsia.","volume":"337","author":"Levine","year":"1997","journal-title":"N Engl J Medicine"},{"key":"R27-9-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1479-828X.1999.tb03434.x","article-title":"Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. FRAGOC and the ACT Study Group.","volume":"39","author":"Crowther","year":"1999","journal-title":"A N Z J Obstet Gynaecol"},{"key":"R28-9-20210126","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJMoa0908056","article-title":"Vitamins C and E to prevent complications of pregnancy-associated hypertension.","volume":"362","author":"Roberts","year":"2010","journal-title":"N Engl J Med"},{"key":"R29-9-20210126","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.2009.02158.x","article-title":"World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries.","volume":"116","author":"Villar","year":"2009","journal-title":"BJOG"},{"key":"R30-9-20210126","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.AOG.0000289576.43441.1f","article-title":"Antioxidant therapy to prevent preeclampsia: a randomized controlled trial.","volume":"110","author":"Spinnato","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R31-9-20210126","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1196\/annals.1331.024","article-title":"Vitamin E in preeclampsia.","volume":"1031","author":"Poston","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R32-9-20210126","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-0528.1990.tb02493.x","article-title":"Fish-oil and pre-eclampsia.","volume":"97","author":"Secher","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"R33-9-20210126","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1471-0528.2000.tb13235.x","article-title":"Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team.","volume":"107","author":"Olsen","year":"2000","journal-title":"BJOG"},{"key":"R36-9-20210126","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","article-title":"European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.","volume":"23","author":"OBrien","year":"2005","journal-title":"J Hypertens"},{"key":"R37-9-20210126","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/bmj.322.7292.981","article-title":"ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques.","volume":"322","author":"Beevers","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"R40-9-20210126","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.AOG.0000118311.18958.63","article-title":"Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy.","volume":"103","author":"Waugh","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"2","key":"R41-9-20210126","first-page":"128","article-title":"Is the urine spot proteincreatinine ratio a valid diagnositic test for pre-eclampsia J Obstet Gynecol.","volume":"31","author":"Sethuram","year":"2011","journal-title":""},{"issue":"7651","key":"R42-9-20210126","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein: creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.","volume":"336","author":"Cote","year":"2008","journal-title":"BMJ"},{"key":"R45-9-20210126","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate The Magpie Trial: a randomized placebo-controlled trial.","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"R46-9-20210126","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJMoa021180","article-title":"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.","volume":"348","author":"Belfort","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"R47-9-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM199507273330401","article-title":"A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.","volume":"333","author":"Lucas","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"R48-9-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2009.04.005","article-title":"Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks gestation: a systematic review and metaanalysis.","volume":"200","author":"Conde-Agudelo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R50-9-20210126","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"R51-9-20210126","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1067\/mob.2002.120280","article-title":"Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas.","volume":"186","author":"Hnat","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"R52-9-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1471-0528.1985.tb01064.x","article-title":"Preeclampsia in second pregnancy.","volume":"92","author":"Campbell","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"R53-9-20210126","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/0002-9378(91)90379-6","article-title":"Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis.","volume":"165","author":"Sibai","year":"1991","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Perinatal &amp; Neonatal Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JPN.0b013e318223ad14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:40:07Z","timestamp":1620956407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005237-201107000-00009"}},"subtitle":["Pathophysiology and Implications for Care"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jpn.0b013e318223ad14","relation":{},"ISSN":["0893-2190"],"issn-type":[{"value":"0893-2190","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}